Progress in the development of cancer vaccines for lung cancer utilizing dendritic cells (Review)
- PMID: 40276084
- PMCID: PMC12018796
- DOI: 10.3892/ol.2025.15044
Progress in the development of cancer vaccines for lung cancer utilizing dendritic cells (Review)
Abstract
Lung cancer is a major global health concern in terms of both incidence and mortality. Despite substantial advancements in targeted therapy and immune checkpoint inhibitor treatments, their overall effectiveness is limited. Dendritic cells (DCs) are crucial in innate and acquired immune responses due to their effective presentation of antigens. DC-based cancer vaccines have been identified as promising strategies for personalized cancer immunotherapy. The present review presents a thorough examination of the immunomodulation and associated mechanisms of DC vaccines in lung cancer, with a specific emphasis on the presentation of clinical trial data concerning the safety, feasibility and effectiveness of DC vaccines in the treatment of patients with lung cancer. The objective of this review is to highlight strategies and provide insights that may improve the development and clinical efficacy of DC vaccines for the treatment lung cancer.
Keywords: dendritic cell vaccine; dendritic cells; lung cancer.
Copyright: © 2025 Hu et al.
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
The Application of Dendritic Cells Vaccines in Tumor Therapy and Their Combination with Biomimetic Nanoparticles.Vaccines (Basel). 2025 Mar 21;13(4):337. doi: 10.3390/vaccines13040337. Vaccines (Basel). 2025. PMID: 40333202 Free PMC article. Review.
-
Dendritic cell-based vaccines, a promising prospect for ending AIDS and eradication of HIV worldwide: A narrative review on the latest updates.Vaccine. 2025 Jun 2;61:127340. doi: 10.1016/j.vaccine.2025.127340. Online ahead of print. Vaccine. 2025. PMID: 40460653 Review.
-
Enhancing Dendritic Cell Cancer Vaccination: The Synergy of Immune Checkpoint Inhibitors in Combined Therapies.Int J Mol Sci. 2024 Jul 9;25(14):7509. doi: 10.3390/ijms25147509. Int J Mol Sci. 2024. PMID: 39062753 Free PMC article. Review.
-
Dendritic cell vaccines in breast cancer: Immune modulation and immunotherapy.Biomed Pharmacother. 2023 Jun;162:114685. doi: 10.1016/j.biopha.2023.114685. Epub 2023 Apr 12. Biomed Pharmacother. 2023. PMID: 37058818 Review.
-
Personalized Neoantigen-Pulsed DC Vaccines: Advances in Clinical Applications.Front Oncol. 2021 Jul 26;11:701777. doi: 10.3389/fonc.2021.701777. eCollection 2021. Front Oncol. 2021. PMID: 34381724 Free PMC article. Review.
References
-
- Zhang M, Wang Y, Chen X, Zhang F, Chen J, Zhu H, Li J, Chen Z, Wang A, Xiao Y, et al. DC vaccine enhances CAR-T cell antitumor activity by overcoming T cell exhaustion and promoting T cell infiltration in solid tumors. Clin Transl Oncol. 2023;25:2972–2982. doi: 10.1007/s12094-023-03161-1. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources